# Mitochondrial Dysfunctions in Human Primary Coenzyme Q10 Deficiencies

**Authors:** Fanny Fontaine, Romain Pénicaud, Stéphane Allouche

PMC · DOI: 10.3390/biom16020302 · Biomolecules · 2026-02-14

## TL;DR

This paper reviews how CoQ10 deficiencies affect mitochondrial function and contribute to a range of human diseases.

## Contribution

The paper provides a comprehensive review of the non-bioenergetic roles of CoQ10 in disease pathophysiology.

## Key findings

- Primary CoQ10 deficiencies are caused by genetic mutations affecting CoQ10 biosynthesis.
- Reduced CoQ10 levels impair mitochondrial functions and lead to diverse clinical manifestations.
- Non-bioenergetic roles of CoQ10, such as antioxidant defense, contribute to disease severity.

## Abstract

Coenzyme Q10 (CoQ10) is an essential lipid-soluble molecule that plays a central role in mitochondrial energy production as a mobile electron carrier. In addition to its bioenergetic function, CoQ10 participates in antioxidant defense, redox homeostasis, lipid and nucleotide metabolism, and mitochondrial quality control. Primary CoQ10 deficiencies are rare inherited mitochondrial disorders caused by pathogenic variants in nuclear genes involved in CoQ10 biosynthesis. These defects lead to reduced CoQ10 levels and impaired mitochondrial functions. Clinically, primary CoQ10 deficiencies display remarkable phenotypic heterogeneity, ranging from isolated organ involvement, notably renal or cerebellar disease, to severe multisystemic disorders affecting the nervous system, skeletal muscle, heart, and other organs. Disease onset spans from the antenatal period to adulthood, and clinical severity varies widely, even among patients carrying variants in the same gene. This diversity cannot be fully explained by defective ATP production alone. Growing evidence indicates that disruption of non-bioenergetic functions of CoQ10, including oxidative stress regulation and CoQ-dependent metabolic pathways, contributes significantly to disease pathophysiology and tissue vulnerability. In this review, we summarize current knowledge on CoQ10 biology, biosynthesis, and the clinical spectrum of primary CoQ10 deficiencies, and we discuss emerging mechanisms linking CoQ10 depletion to mitochondrial dysfunctions and human diseases.

## Linked entities

- **Chemicals:** Coenzyme Q10 (PubChem CID 5281915), CoQ10 (PubChem CID 5281915)

## Full-text entities

- **Genes:** COQ10B (coenzyme Q10B) [NCBI Gene 80219], ETFDH (electron transfer flavoprotein dehydrogenase) [NCBI Gene 2110] {aka ETFQO, MADD}, COQ8A (coenzyme Q8A) [NCBI Gene 56997] {aka ADCK3, ARCA2, CABC1, COQ10D4, COQ8, SCAR9}, TXNIP (thioredoxin interacting protein) [NCBI Gene 10628] {aka ARRDC6, EST01027, HHCPA78, THIF, VDUP1}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, CD200 (CD200 molecule) [NCBI Gene 4345] {aka MOX1, MOX2, MRC, OX-2}, CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}, LPL (lipoprotein lipase) [NCBI Gene 4023] {aka HDLCQ11, LIPD}, TLR9 (toll like receptor 9) [NCBI Gene 54106] {aka CD289}, TST (thiosulfate sulfurtransferase) [NCBI Gene 7263] {aka RDS}, UBIAD1 (UbiA prenyltransferase domain containing 1) [NCBI Gene 29914] {aka SCCD, TERE1}, Sqor (sulfide quinone oxidoreductase) [NCBI Gene 59010] {aka 0610039J17Rik, 4930557M22Rik, Sqrdl}, CHDH (choline dehydrogenase) [NCBI Gene 55349], STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061] {aka ERIS, MITA, MPYS, NET23, SAVI, STING}, SOD2 (superoxide dismutase 2) [NCBI Gene 6648] {aka GC1, GClnc1, IPO-B, IPOB, MNSOD, MVCD6}, FDPS (farnesyl diphosphate synthase) [NCBI Gene 2224] {aka FPPS, FPS, POROK9}, MAP1LC3A (microtubule associated protein 1 light chain 3 alpha) [NCBI Gene 84557] {aka ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, GPD2 (glycerol-3-phosphate dehydrogenase 2) [NCBI Gene 2820] {aka GDH2, GPDM, mGDH, mGPDH}, FUNDC1 (FUN14 domain containing 1) [NCBI Gene 139341], PDSS2 (decaprenyl diphosphate synthase subunit 2) [NCBI Gene 57107] {aka C6orf210, COQ10D3, COQ1B, DLP1, bA59I9.3, hDLP1}, RET (ret proto-oncogene) [NCBI Gene 5979] {aka CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1}, ACADS (acyl-CoA dehydrogenase short chain) [NCBI Gene 35] {aka ACAD3, SCAD}, SOD3 (superoxide dismutase 3) [NCBI Gene 6649] {aka EC-SOD}, COQ2 (coenzyme Q2, polyprenyltransferase) [NCBI Gene 27235] {aka CL640, COQ10D1, MSA1, PHB:PPT}, COQ3 (coenzyme Q3, methyltransferase) [NCBI Gene 51805] {aka DHHBMT, DHHBMTASE, UG0215E05, bA9819.1}, SQOR (sulfide quinone oxidoreductase) [NCBI Gene 58472] {aka CGI-44, PRO1975, SQR, SQRDL}, LDHD (lactate dehydrogenase D) [NCBI Gene 197257] {aka DLACD}, NQO1 (NAD(P)H quinone dehydrogenase 1) [NCBI Gene 1728] {aka DHQU, DIA4, DTD, NMOR1, NMORI, QR1}, GSR (glutathione-disulfide reductase) [NCBI Gene 2936] {aka CNSHA10, GR, GSRD, HEL-75, HEL-S-122m}, ATG12 (autophagy related 12) [NCBI Gene 9140] {aka APG12, APG12L, FBR93, HAPG12}, PRKN (parkin RBR E3 ubiquitin protein ligase) [NCBI Gene 5071] {aka AR-JP, LPRS2, PARK2, PDJ}, PAH (phenylalanine hydroxylase) [NCBI Gene 5053] {aka PH, PKU, PKU1}, Dhodh (dihydroorotate dehydrogenase) [NCBI Gene 56749] {aka 2810417D19Rik}, S100A4 (S100 calcium binding protein A4) [NCBI Gene 6275] {aka 18A2, 42A, CAPL, FSP1, MTS1, P9KA}, ALDH7A1 (aldehyde dehydrogenase 7 family member A1) [NCBI Gene 501] {aka ATQ1, EPD, EPEO4, PDE}, AIFM2 (AIF family member 2, ferroptosis suppressor) [NCBI Gene 84883] {aka AMID, FSP1, PRG3}, PINK1 (PTEN induced kinase 1) [NCBI Gene 65018] {aka BRPK, PARK6}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, PDSS1 (decaprenyl diphosphate synthase subunit 1) [NCBI Gene 23590] {aka COQ1, COQ10D2, COQ1A, DPS, SPS, TPRT}, STARD7 (StAR related lipid transfer domain containing 7) [NCBI Gene 56910] {aka ADCME, BAFME2, FAME, FAME2, FCMTE2, GTT1}, COQ8B (coenzyme Q8B) [NCBI Gene 79934] {aka ADCK4, NPHS9}, DHODH (dihydroorotate dehydrogenase (quinone)) [NCBI Gene 1723] {aka DHOdehase, POADS, URA1}, GYPC (glycophorin C (Gerbich blood group)) [NCBI Gene 2995] {aka CD236, CD236R, GE, GPC, GPD, GYPD}, SUOX (sulfite oxidase) [NCBI Gene 6821], COX8A (cytochrome c oxidase subunit 8A) [NCBI Gene 1351] {aka COX, COX8, COX8-2, COX8L, MC4DN15, VIII}, AADAT (aminoadipate aminotransferase) [NCBI Gene 51166] {aka KAT2, KATII, KYAT2}, GPX2 (glutathione peroxidase 2) [NCBI Gene 2877] {aka GI-GPx, GPRP, GPRP-2, GPx-2, GPx-GI, GSHPX-GI}, GPX4 (glutathione peroxidase 4) [NCBI Gene 2879] {aka GPx-4, GSHPx-4, MCSP, PHGPx, SMDS, snGPx}, Pdss2 (prenyl (solanesyl) diphosphate synthase, subunit 2) [NCBI Gene 71365] {aka 5430420P03Rik, Gm60, Plmp, kd, mDLP1}, GPX1 (glutathione peroxidase 1) [NCBI Gene 2876] {aka GPXD, GSHPX1}, COQ10A (coenzyme Q10A) [NCBI Gene 93058], GSTK1 (glutathione S-transferase kappa 1) [NCBI Gene 373156] {aka GST, GST 13-13, GST13, GST13-13, GSTK1-1, hGSTK1}, COQ6 (coenzyme Q6, monooxygenase) [NCBI Gene 51004] {aka CGI-10, CGI10, COQ10D6}, COQ9 (coenzyme Q9) [NCBI Gene 57017] {aka C16orf49, COQ10D5}, COQ7 (coenzyme Q7, hydroxylase) [NCBI Gene 10229] {aka CAT5, COQ10D8, HMNR9}, D2HGDH (D-2-hydroxyglutarate dehydrogenase) [NCBI Gene 728294] {aka D2HGD}, ETHE1 (ETHE1 persulfide dioxygenase) [NCBI Gene 23474] {aka HSCO, YF13H12}, PRODH (proline dehydrogenase 1) [NCBI Gene 5625] {aka HSPOX2, PIG6, POX, PRODH1, TP53I6}, HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase) [NCBI Gene 3156] {aka LDLCQ3, LGMDR28, MYPLG}
- **Diseases:** arrhythmia (MESH:D001145), lesions (MESH:D009059), focal segmental glomerulosclerosis (MESH:D005923), cerebral anomalies (MESH:C563612), pigmentary retinopathy (MESH:D012174), tachycardia (MESH:D013610), Cerebellar atrophy or hypoplasia (MESH:C562568), pes cavus (MESH:D000070589), infantile spasms (MESH:D013036), developmental defects (MESH:D000094602), hepatic steatosis (MESH:D005234), hammer toes (MESH:D037801), left ventricular hypoplasia (MESH:D018487), respiratory (MESH:D012131), White matter abnormalities (MESH:D056784), sclerosis (MESH:D012598), spastic-ataxic gait (MESH:D020233), energy (MESH:D011502), thin corpus callosum (MESH:C538335), acute kidney injury (MESH:D058186), Stroke (MESH:D020521), oculomotor abnormalities (MESH:D015840), microcephaly (MESH:D008831), Cervical or focal dystonia (MESH:D014103), reduced fetal movements (MESH:D005315), fatigue (MESH:D005221), mitral dysplasia (MESH:D008946), mitochondrial complex I dysfunction (MESH:C537475), Cognitive symptoms (MESH:D019954), cardiomyopathy (MESH:D009202), dysarthria (MESH:D004401), mtDNA depletion (MESH:C536350), tubulopathy (MESH:C557674), multisystemic disorders (MESH:D019578), nystagmus (MESH:D009759), intellectual impairment (MESH:C565406), cerebellar atrophy (MESH:D002526), Spastic paraplegia (MESH:D010264), respiratory distress (MESH:D012128), atrial or ventricular septal defects (MESH:D006345), Primary Deficiency (MESH:D000081207), proteinuria (MESH:D011507), hearing loss (MESH:D034381), neurological and renal abnormalities (MESH:D009461), COQ9-related disease (MESH:D000077733), autosomal recessive disorder (MESH:D030342), CHDH dysfunction (MESH:D002796), Sensorineural impairment (MESH:D006319), seizures (MESH:D012640), renal (MESH:D006030), bradycardia (MESH:D001919), muscular contractures (MESH:D003286), axonal (MESH:D012183), damage to (MESH:D020263), Dystonia (MESH:D004421), fibrosis (MESH:D005355), IUGR (MESH:D005317), Muscle involvement (MESH:C566343), Spasticity (MESH:D009128), injury to (MESH:D014947)
- **Chemicals:** cardiolipin (MESH:D002308), 1-pyrroline-5-carboxylate (MESH:C015485), G3P (MESH:C029620), kaempferol (MESH:C006552), L (MESH:D007930), phospholipids (MESH:D010743), water (MESH:D014867), tyrosine (MESH:D014443), acetylcholine (MESH:D000109), S-adenosyl methionine (MESH:D012436), phosphatidylglycerol (MESH:D010715), isoprenoid (MESH:D013729), 3-polyprenyl-4-hydroxy-benzoate (MESH:C003188), nucleotide (MESH:D009711), acetyl-CoA (MESH:D000105), Fe-S (MESH:D007501), isoprene (MESH:C005059), ascorbate (MESH:D001205), trans-4-hydroxy-L-proline (MESH:C000716210), 4-HNE (MESH:C027576), glutamate (MESH:D018698), isoprostanes (MESH:D028421), branched-chain amino acids (MESH:D000597), 4-HB (MESH:C038193), sugar-phosphate (MESH:D013403), resveratrol (MESH:D000077185), HO (MESH:D017665), Pyrimidine (MESH:C030986), aldehyde (MESH:D000447), galactose (MESH:D005690), ethanol (MESH:D000431), PPP (MESH:C008981), glyoxylate (MESH:C031150), cholesterol (MESH:D002784), L-proline (MESH:D011392), 2-hydroxyglutarate (MESH:C019417), beta-hydroxybutyrate (MESH:D020155), pyruvate (MESH:D019289), fat (MESH:D005223), methionine (MESH:D008715), glucuronide (MESH:D020719), mevalonate (MESH:D008798), succinate (MESH:D019802), sulfate (MESH:D013431), molecular oxygen (MESH:D010100), decylubiquinone (MESH:C060262), vanillic acid (MESH:D014641), Sulfide (MESH:D013440), uridine (MESH:D014529), glutathione persulfide (MESH:C000611742), 4-HBz (MESH:C011483), glycerophospholipids (MESH:D020404), glycosphingolipids (MESH:D006028), Choline (MESH:D002794), orotate (MESH:D009963), VIT E (MESH:D014810), FMNH2 (MESH:C540087), C4- (MESH:C058899), TCA (MESH:D014233), carbon (MESH:D002244)
- **Species:** Sus scrofa (pig, species) [taxon 9823], Escherichia coli (E. coli, species) [taxon 562], Mus musculus (house mouse, species) [taxon 10090], Caenorhabditis elegans (species) [taxon 6239], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Equus caballus (domestic horse, species) [taxon 9796], Danio rerio (leopard danio, species) [taxon 7955], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** phenylalanine into tyrosine, R239X
- **Cell lines:** 143B — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_2270), HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938788/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938788/full.md

## References

249 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938788/full.md

---
Source: https://tomesphere.com/paper/PMC12938788